Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

NCT03886246 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Pustular Psoriasis

Interventions

DRUG: Spesolimab
DRUG: Spesolimab

Sponsor

Boehringer Ingelheim